Tsiri Agbenyega

Kwame Nkrumah University of Science and Technology — GH

Medicine · Health Sciences

43h-index7.0kcitations133works11.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(75), Mosquito-borne diseases and control(46), Hemoglobinopathies and Related Disorders(15), Global Maternal and Child Health(12), Parasites and Host Interactions(12)

Publications133 total

Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial
The Lancet Global Health·2025· 1 citedOpen Access
Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9–14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial
The Lancet Infectious Diseases·2025· 6 citedOpen Access
Longitudinal associations of plasma amino acid levels with recovery from malarial coma
Malaria Journal·2024· 1 citedOpen Access
Detection of naturally acquired, strain-transcending antibodies against rosetting <i>Plasmodium falciparum</i> strains in humans
Infection and Immunity·2024· 2 citedOpen Access
Longitudinal associations of plasma amino acid levels with recovery from malarial coma
2024· 1 citedOpen Access
Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial
The Lancet Infectious Diseases·2024· 16 citedOpen Access
Feasibility, safety, and impact of the RTS,S/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi
The Lancet·2024· 70 citedOpen Access
Could Less Be More? Accounting for Fractional-Dose Regimens and Different Number of Vaccine Doses When Measuring the Impact of the RTS,S/AS01E Malaria Vaccine
The Journal of Infectious Diseases·2024· 4 citedOpen Access
Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9–14 years of age: Interim analysis from a phase 3 clinical trial
Vaccine·2024· 22 citedOpen Access
Detection of naturally acquired, strain-transcending antibodies against rosetting <i>Plasmodium falciparum</i> strains in humans
2024· 2 citedOpen Access
Immunogenicity and Safety of Escherichia Coli-Produced Bivalent Human Papillomavirus Vaccine in Girls 9–14 Years of Age in Low- and Middle-Income Countries: Final Data of Randomized Controlled Trial
SSRN Electronic Journal·2024Open Access
Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacy
2023Open Access
Prostration and the prognosis of death in African children with severe malaria
International Journal of Infectious Diseases·2023· 2 citedOpen Access
Feasibility, Safety, and Impact of the RTS,S/AS01&lt;sub&gt;E&lt;/sub&gt; Malaria Vaccine When Implemented Through National Immunisation Programmes: Evaluation of Cluster-Randomized Introduction of the Vaccine in Ghana, Kenya, and Malawi
SSRN Electronic Journal·2023· 5 citedOpen Access
Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial
The Lancet Infectious Diseases·2022· 67 citedOpen Access
Are Malaria Risk Factors Based on Gender? A Mixed-Methods Survey in an Urban Setting in Ghana
Tropical Medicine and Infectious Disease·2021· 42 citedOpen Access
Human genetic variant E756del in the ion channel PIEZO1 not associated with protection from severe malaria in a large Ghanaian study
Journal of Human Genetics·2021· 12 citedOpen Access
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
UNC Libraries·2021Open Access
Are Malaria Risk Factors based on Gender? A Mixed-methods Survey in an Urban Setting in Ghana.
2021· 13 citedOpen Access
Effects of Intravenous Agent Used on Oxygen Desaturation during Suxamethonium Apnoea
OALib·2021Open Access
page 1 of 7Next →

Frequent Co-authors

Daniel Ansong(20), Sanjeev Krishna(14), Kalifa Bojang(12), Peter G. Kremsner(11), Terrie E. Taylor(9), Seth Owusu‐Agyei(8), Kwaku Poku Asante(8), Jennifer Evans(7), Brian Greenwood(7), Kevin Marsh(7), Taane G. Clark(7), Dominic Kwiatkowski(7), Justice Sylverken(7), Charles R. Newton(7), Marc Lievens(6), Samuel Adjei(6), Ogobara K. Doumbo(6), Rolf D. Horstmann(6), George Bedu‐Addo(6), Samwel Gesase(5)